U.S. Congress legislation · 119th Congress
SB5316: BINSA Act
Status: In committee, August 6, 2026
A bill to amend title VIII of the Defense Production Act of 1950 to include biotechnology in the definitions of "prohibited technology" and "notifiable technology", and for other purposes.
What the bill says
To amend title VIII of the Defense Production Act of 1950 to include biotechnology in the definitions of prohibited technology and notifiable technology , and for other purposes.
From the introduced text, August 6, 2026:
A BILL To amend title VIII of the Defense Production Act of 1950 to include biotechnology in the definitions of prohibited technology and notifiable technology , and for other purposes. SECTION 1. Short title This Act may be cited as the Biotech Investment National Security Act of 2026 or the BINSA Act . SECTION 2. Findings; sense of Congress (a) Findings Congress finds the following: (1) The People's Republic of China has pursued a deliberate, state-directed strategy to dominate global biotechnology, including pharmaceutical development, biologics manufacturing, and clinical research and development capabilities. (2) United States capital flowing to Chinese biotechnology companies through licensing agreements, joint ventures, and equity investments is accelerating the acquisition by the People's Republic of China of pharmaceutical intellectual property and clinical development capabilities in a manner that creates strategic dependency risks for the United States. (3) Cross-border out-licensing transactions between United States and European pharmaceutical companies and Chinese biotechnology firms totaled approximately $136,000,000,000 in 2025, representing a rapid and accelerating transfer of pharmaceutical innovation capacity to entities subject to the direction and control of the People's Republic of China. (4) Biotechnology, including pharmaceutical development and biologics manufacturing, has civil-military dual-use applications and presents strategic dependency risks for the United States comparable to those presented by semiconductors, artificial intelligence, and other technologies already covered by title VIII …
Sponsors
- Ricketts, Pete (R) · primary sponsor
- Slotkin, Elissa (D)
Latest actions
- : Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
- : Introduced in Senate
Subjects: International Affairs
Common questions
- What is SB5316?
- SB5316 is a bill in Congress (119th Congress): BINSA Act.
- What does SB5316 do?
- In its own words: To amend title VIII of the Defense Production Act of 1950 to include biotechnology in the definitions of prohibited technology and notifiable technology , and for other purposes.
- What is the status of SB5316?
- In committee as of August 6, 2026. Latest action: Read twice and referred to the Committee on Banking, Housing, and Urban Affairs. (August 6, 2026).
- Who sponsored SB5316?
- Ricketts, Pete (R), with 1 co-sponsor.
- Where is the official record for SB5316?
- On the Congress website: https://www.congress.gov/bill/119th-congress/senate-bill/5316
Source: official Congress record. Tracked by Delilah, AI for legislation across all 50 states and Congress.